Cargando…
Tiling resolution array CGH and high density expression profiling of urothelial carcinomas delineate genomic amplicons and candidate target genes specific for advanced tumors
BACKGROUND: Urothelial carcinoma (UC) is characterized by nonrandom chromosomal aberrations, varying from one or a few changes in early-stage and low-grade tumors, to highly rearranged karyotypes in muscle-invasive lesions. Recent array-CGH analyses have shed further light on the genomic changes und...
Autores principales: | Heidenblad, Markus, Lindgren, David, Jonson, Tord, Liedberg, Fredrik, Veerla, Srinivas, Chebil, Gunilla, Gudjonsson, Sigurdur, Borg, Åke, Månsson, Wiking, Höglund, Mattias |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2227947/ https://www.ncbi.nlm.nih.gov/pubmed/18237450 http://dx.doi.org/10.1186/1755-8794-1-3 |
Ejemplares similares
-
A Systematic Study of Gene Mutations in Urothelial Carcinoma; Inactivating Mutations in TSC2 and PIK3R1
por: Sjödahl, Gottfrid, et al.
Publicado: (2011) -
DNA methylation analyses of urothelial carcinoma reveal distinct epigenetic subtypes and an association between gene copy number and methylation status
por: Lauss, Martin, et al.
Publicado: (2012) -
Integrated Genomic and Gene Expression Profiling Identifies Two Major Genomic Circuits in Urothelial Carcinoma
por: Lindgren, David, et al.
Publicado: (2012) -
Recurrent and multiple bladder tumors show conserved expression profiles
por: Lindgren, David, et al.
Publicado: (2008) -
HER2 and EGFR amplification and expression in urothelial carcinoma occurs in distinct biological and molecular contexts
por: Eriksson, Pontus, et al.
Publicado: (2017)